Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Langenau, David M  [Clear All Filters]
Journal Article
Chen EY, Dobrinski KP, Brown KH, Clagg R, Edelman E, Ignatius MS, Chen JYun Helen, Brockmann J, G Nielsen P, Ramaswamy S, et al. Cross-species array comparative genomic hybridization identifies novel oncogenic events in zebrafish and human embryonal rhabdomyosarcoma. PLoS Genet. 2013;9(8):e1003727.
Ignatius MS, Hayes MN, Moore FE, Tang Q, Garcia SP, Blackburn PR, Baxi K, Wang L, Jin A, Ramakrishnan A, et al. deficiency causes a wide tumor spectrum and increases embryonal rhabdomyosarcoma metastasis in zebrafish. Elife. 2018;7.
Prajapati K, Yan C, Yang Q, Arbitman S, Fitzgerald DP, Sharee S, Shaik J, Bosiacki J, Myers K, Paucarmayta A, et al. The FLRT3-UNC5B checkpoint pathway inhibits T cell-based cancer immunotherapies. Sci Adv. 2024;10(9):eadj4698.
Albacker CE, Storer NY, Langdon EM, Dibiase A, Zhou Y, Langenau DM, Zon LI. The Histone Methyltransferase SUV39H1 Suppresses Embryonal Rhabdomyosarcoma Formation in Zebrafish. PLoS One. 2013;8(5):e64969.
Tenente IM, Tang Q, Moore JC, Langenau DM. Normal and Malignant Muscle Cell Transplantation into Immune Compromised Adult Zebrafish. J Vis Exp. 2014;(94).
Yan C, Yang Q, Zhang S, Millar DG, Alpert EJ, Do D, Veloso A, Brunson DC, Drapkin BJ, Stanzione M, et al. Single-cell imaging of T cell immunotherapy responses in vivo. J Exp Med. 2021;218(10).
Blackburn JS, Langenau DM. Zebrafish as a model to assess cancer heterogeneity, progression and relapse. Dis Model Mech. 2014;7(7):755-762.
Fazio M, Ablain J, Chuan Y, Langenau DM, Zon LI. Zebrafish patient avatars in cancer biology and precision cancer therapy. Nat Rev Cancer. 2020.
Storer NY, White RM, Uong A, Price E, G Nielsen P, Langenau DM, Zon LI. Zebrafish rhabdomyosarcoma reflects the developmental stage of oncogene expression during myogenesis. Development. 2013;140(14):3040-3050.